Human Pharma
Pipeline
Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation. With a pipeline of around 90 clinical and pre-clinical projects, with the potential to deliver up to 15 new medicines by 2025, we continue our track record of long-term innovation-led performance.
-
Human Pharma Pipeline
Pipeline
This represents a selection of assets in our research and development portfolio in April 2019.